Semuloparin

Identification

Name
Semuloparin
Accession Number
DB06294
Description
Not Available
Type
Small Molecule
Groups
Investigational
Synonyms
  • Octaparin
  • Octaparine
External IDs
  • AVE-5026
  • AVE5026

Pharmacology

Indication

Investigated for use/treatment in thrombosis.

Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbciximabThe risk or severity of bleeding can be increased when Abciximab is combined with Semuloparin.
AceclofenacThe risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Semuloparin.
AcemetacinThe risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Semuloparin.
AcenocoumarolThe risk or severity of bleeding can be increased when Acenocoumarol is combined with Semuloparin.
Acetylsalicylic acidAcetylsalicylic acid may increase the anticoagulant activities of Semuloparin.
Albutrepenonacog alfaThe therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Semuloparin.
AlclofenacThe risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Semuloparin.
AldesleukinThe risk or severity of bleeding can be increased when Semuloparin is combined with Aldesleukin.
AlemtuzumabThe risk or severity of bleeding can be increased when Semuloparin is combined with Alemtuzumab.
AlteplaseThe risk or severity of bleeding can be increased when Alteplase is combined with Semuloparin.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
  • Avoid herbs and supplements with anticoagulant/antiplatelet activity. Examples include garlic, ginger, bilberry, danshen, piracetam, and ginkgo biloba.

Products

Product Ingredients
IngredientUNIICASInChI Key
Semuloparin sodiumV5T10N50RDNot AvailableNot applicable
International/Other Brands
Mulsevo

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
4QW4AN84NQ
CAS number
Not Available

References

General References
Not Available
RxNav
2368733
Wikipedia
Semuloparin_sodium

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3CompletedPreventionMalignancies / Venous Thromboembolism1
3CompletedPreventionVenous Thromboembolism5
3TerminatedPreventionVenous Thromboembolism1
2CompletedPreventionVenous Thromboembolism1
2TerminatedPreventionThrombosis Prophylaxis (Risk of Thrombosis Due to Central Venous Line (CVL)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on March 19, 2008 10:22 / Updated on July 10, 2020 21:42

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates